Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.33), $0.15 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.